Final answer:
Overexpression of a gene in cancer is likely associated with acetylation of histones, leading to increased gene expression. Histone acetyl transferases (HATs) add acetyl groups to histones, promoting gene expression, while histone deacetylases (HDACs) remove acetyl groups, leading to gene silencing.
Step-by-step explanation:
In cancer cells, alteration to epigenetic modifications turns off genes that are normally expressed. Specifically, overexpression of a gene in cancer is likely associated with acetylation of histones.
Histone acetylation leads to increased gene expression by loosening the tightly wound DNA, allowing transcription factors and RNA polymerase to access the gene and initiate transcription.
Histone acetyl transferases (HATs) are enzymes that add acetyl groups to histones, promoting gene expression. On the other hand, histone deacetylases (HDACs) remove acetyl groups, leading to gene silencing. In the case of overexpression of a gene in cancer, there would likely be increased histone acetylation due to the activity of HATs and decreased activity of HDACs.